Next Article in Journal
Compilation of Secondary Metabolites from Bidens pilosa L.
Previous Article in Journal
Comparative Anti-Infectious Bronchitis Virus (IBV) Activity of (-)-Pinene: Effect on Nucleocapsid (N) Protein
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 16
Issue 2
10.3390/molecules16021055
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antioxidant Activity of β-Carotene Compounds in Different in Vitro Assays

by
Lars Mueller
and
Volker Boehm
*
Institute of Nutrition, Friedrich Schiller University Jena, Dornburger Straße 25-29, 07743 Jena, Germany
*
Author to whom correspondence should be addressed.
Molecules 2011, 16(2), 1055-1069; https://doi.org/10.3390/molecules16021055
Submission received: 17 December 2010 / Revised: 13 January 2011 / Accepted: 18 January 2011 / Published: 25 January 2011
(This article belongs to the Section Natural Products Chemistry)
Browse Figures
Versions Notes

Abstract

:
β-Carotene (BC) is the most abundant carotenoid in human diet, almost solely as (all-E)-isomer. Significant amounts of (Z)-isomers of BC are present in processed food as well as in mammalian tissues. Differences are described for the activity of various BC isomers in forming retinal and protecting against cancer and cardiovascular diseases. Eccentric cleavage of BC leads to degradation products such as carotenals. A variety of negative consequences were published for the non-vitamin A active BC metabolites, such as inducing the carcinogenesis of benzo[a]pyrene, impairing mitochondrial function, or increasing CYP activity. To increase the knowledge on the antioxidant activity, a variety of BC isomers and metabolites were tested in various in vitro assays.
In the present study, no ferric reducing activity (FRAP assay) was observed for the BC isomers. Between the major BC isomers (all-E, 9Z, and 13Z) no significant differences in bleaching the ABTS●+ (αTEAC assay) or in scavenging peroxyl radicals (ROO●) generated by thermal degradation of AAPH (using a chemiluminescence assay) were detected. However, the (15Z)-isomer was less active, maybe due to its low stability. The degradation to β-apo-carotenoids increased FRAP activity and ROO● scavenging activity compared to the parent molecule. Dependence on chain length and character of the terminal function was determined in αTEAC assay with following order of increasing activity: β-apo-8’-carotenal < β-apo-8’-carotenoic acid ethyl ester < 6’-methyl-β-apo-6’-carotene-6’-one (citranaxanthin). The results indicate that BC does not lose its antioxidant activity by degradation to long chain breakdown products.

Introduction

Carotenoids are a widespread group of naturally occurring fat-soluble colorants. In developed countries, 80-90% of the carotenoid intake comes from fruit and vegetable consumption. Of the more than 700 naturally occurring carotenoids identified thus far, approx. 50 are present in the human diet and can be absorbed and metabolized by the human body [1]. However, only six of them (β-carotene, β-cryptoxanthin, α-carotene, lycopene, lutein and zeaxanthin) account for more than 95% of total blood carotenoids. β-Carotene (BC) is a naturally occurring orange-colored carbon-hydrogen carotenoid, abundant in yellow-orange fruits and vegetables and in dark green, leafy vegetables [2]. It is also the most widely distributed carotenoid in foods [3]. BC undergoes trans (E) to cis (Z) isomerization [4], whereas the (all-E)-form is the predominant isomer found in unprocessed carotene-rich plant foods [5,6]. Food processing or long-term storage of carotenoid-rich vegetables can lead to degradation and/or isomerization of carotenoids [1,7]. Although low concentrations are found in circulating human serum, BC (Z)-isomers are present in human tissues where it is expected to exert their biological function(s) [8]. Significant amounts of (9Z)-, (13Z)-, and (15Z)-isomers of BC were found in liver, kidney, adrenal gland and testes up to 25% of the total BC, whereas in human serum (all-E)-BC was the dominant isomer with 95% of the total BC amount [9]. Chemical structures of the main BC isomers found in food and human tissues are shown in Figure 1.
Molecules 16 01055 g001 550
Figure 1. Structures of analyzed β-carotene (BC) isomers and metabolites.
Figure 1. Structures of analyzed β-carotene (BC) isomers and metabolites.
Molecules 16 01055 g001
Nutrition has a significant role in the prevention of many chronic diseases such as cardiovascular diseases (CVD), cancers, and degenerative brain diseases [10]. The consumption of food-based antioxidants like BC seems to be useful for the prevention of macular degeneration and cataracts [11]. Numerous epidemiological studies have suggested an inverse relationship between intake of BC, fruits and vegetables, particularly raw fruits and vegetables and dark green, leafy and cruciferous vegetables, and the risk of oesophageal adenocarcinoma and Barrett's oesophagus [12]. Additionally, several studies have observed a protective effect of BC from foods, along with a diet rich in fruits and vegetables, on liver carcinogenesis and lung disease [13,14]. BC has potential antioxidant biological properties due to its chemical structure (see Figure 1) and interaction with biological membranes [15]. It is well-known, that BC quenches singlet oxygen with a multiple higher efficiency than α-tocopherol. [16]. In addition, it was shown that (Z)-isomers of BC possess antioxidant activity in vitro [17,18,19].
In contrast, three large BC intervention trials: the β-Carotene and Retinol Efficacy Trial (CARET), the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study (ATBC), and the Physician's Health Study (PHS) have all pointed to a lack of effect of synthetic BC in decreasing cardiovascular disease or cancer risk in well-nourished populations up to increased lung cancer incidence and mortality in smokers [14,20,21].
In vertebrates, BC is converted into two molecules of retinal, in a reaction catalyzed by β,β-carotene-15,15’-monooxygenase (BCMO I), like other provitamin A carotenoids too [22]. Of the 50 different carotenoids that can be metabolized into vitamin A, BC has the highest provitamin A activity [2]. The formed retinal is further metabolized to the vitamin A derivatives retinoic acid (RA) and retinol. The provitamin A activity of (Z)-isomers is much lower than that of (all-E)-BC. (9Z)-BC has a relative bioconversion to retinol of 38%, (13Z)-BC 53% whereas the (all-E)-form is 100% [23]. Besides being essential for vision, RA is a major signal pathway controlling molecule which regulates a wide range of biological processes. RA is the ligand of two classes of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). (all-E)-BC is a precursor of (all-E)-RA, which preferentially binds to RARs, whereas (9Z)-BC is a precursor of (9Z)-RA – the preferred ligand for RXRs [24].
In addition to this central cleavage pathway, an eccentric cleavage was proposed in healthy mammals after incubation of BC with liver, kidney and lung homogenate of rats, ferrets, and monkeys [25]. By stepwise oxidation from one end of the polyene chain a sequence of β-apo-carotenal derivatives were presumably formed, e.g. β-apo-8’-carotenal (shown in Figure 1). The formed aldehydes were further cleaved to short-chain carbonyl compounds, or converted to β-apo-carotenol, β-apo-carotenoic acids or their esters, or oxidized to retinoic acid by β-oxidation pathways [26,27]. The three apo-carotenoids studied herein are used as colorants in animal feed and human food. β-apo-8’-Carotenal and β-apo-8’-carotenoic acid ethyl ester are present in some fruits and vegetables, though in low amounts [28], and were recently detected in human plasma [27].
In addition to the enzymatic cleavage of BC in mammalian metabolism, free radical attack on BC results in the formation of high amounts of cleavage products. For instance, β-apo-8’-carotenal and 6’-methyl-β-apo-6’-carotene-6’-one (citranaxanthin), shown in Figure 1, were identified in minor amounts in intestinal extracts of vitamin A deficient rats [29]. The results of Allija et al. [30] indicate a genotoxic potential of BC cleavage products at physiologically relevant levels of BC and its breakdown products. In contrast, BC itself did not induce cytotoxic or genotoxic effects. Furthermore, when BC was supplemented to primary hepatocytes a dose-dependent increase of cleavage products was observed accompanied by increasing genotoxicity [30]. The authors speculated that these results provide strong evidence that BC breakdown products are responsible for the occurrence of carcinogenic effects found in the Alpha-Tocopherol Beta-Carotene Cancer prevention (ATBC) study and the β-Carotene and Retinol Efficacy (CARET) Trial.
In contrast to the physiologically relevant properties, such as influencing cellular signal pathways, gene expression or induction of detoxifying enzymes, the knowledge on antioxidant potential of BC compounds is scarce. Therefore, the aim of the study was to investigate both BC isomers and some non-retinoic metabolites on their antioxidant activity in various in vitro assays, compared to another nutritionally relevant substance – vitamin E (α-tocopherol).

Results and Discussion

It has been known for many years that carotenoids undergo ‘‘bleaching’’ i. e., lose their color, when exposed to radicals or to oxidizing species. This process involves interruption of the conjugated double bond system either by cleavage or by addition to one of the double bonds. Cleavage can be detected by characterizing the products that are formed, which are frequently carbonyls or epoxides [2]. In the present study, four isomers and three metabolites of β-carotene (BC) were analyzed on their antioxidant activity in three different in vitro assays. There are at least three possible mechanisms for the reaction of carotenoids with radical species. They include (1) radical addition; (2) electron transfer to the radical; or (3) allylic hydrogen abstraction [2].
The ability of BC and its degradation products to undergo single electron transfer-based reactions (SET) was utilized in the analysis of ferric reducing (FRAP) and ABTS●+ bleaching (αTEAC) activity. Electron transfer reactions have been reported, resulting in the formation of a carotenoid cation radical (CAR●+) [31]. Such a cationic radical of BC or its metabolites is entirely conceivable in the reactions with the ferric ion or the synthetic ABTS●+.
In the αTEAC assay, the investigated (all-E)-BC and its (Z)-isomers showed 3-times higher ABTS●+ bleaching activity than α-tocopherol [Figure 2(A)]. The results of Böhm et al. showed an antioxidant activity of the BC isomers dissolved in n-hexane, marginal higher than that of the calibration compound Trolox®. This hydrophilic analogue of α-tocopherol was dissolved in PBS [19]. In the present study, the reference compound α-tocopherol was dissolved in n-hexane to be more comparable to the reaction conditions used for the carotenoids. The differences in the reference compound used and in the reaction conditions might have caused the different TEAC values of BC. To date, published results on antioxidant activity of BC isomers in vitro differ due to the use of different test systems. Often (9Z)-BC was more effective than its (all-E)-isomer [17,18,32]. In contrast, there are also investigations under identical conditions which support our results. The studies of Böhm and colleagues showed that the ABTS●+ bleaching activity of BC isomers is independent from position of the cis-double bond [19]. No significant dependence (p > 0.05) of the position of the cis-double bond was observed between (all-E)-, (9Z)-, and (13Z)-BC (approx. 3 mol α-TE/mol) in our investigations. However, (15Z)-BC displayed a 20% lower activity (2.5 mol α-TE/mol) in this assay (p < 0.05). The advanced hindrance between the steric demanding bicyclic carotenoid molecule with a centered cis-double bond and the similarly demanding oxidizing agent ABTS●+ might have caused this lower activity. The relation of steric demand of ABTS and carotenoids was demonstrated several times [33,34]. Ascorbic acid and phenolic antioxidants like flavonoids, phenolic acids (hydroxylated benzoic acids and cinnamic acids) and tocopherols excite their antioxidant potential by hydroxyl groups at the outer part of the molecule reacting with radicals combined with a conjugated double bond system in vicinity [33,34]. Consequently, a resonance-stabilized radical is formed [37,38]. However, the reactive part of carotenes, like lycopene, α- and β-carotene, is the conjugated polyene chain in the center of the molecule [39]. This fact makes it difficult for steric demanding oxidants to interact with the carotenoid, especially with the bicyclic structures of β-carotene. The results obtained in the FRAP assay, described below, support this hypothesis. Additionally, (15Z)-BC is the BC isomer with the lowest stability [40,41] investigated in the present work, due to the higher potential energy of its cis-bond. This may have led to a degradation of this isomer during analysis, and consequently a lower antioxidant activity was determined.
Molecules 16 01055 g002 550
Figure 2. Antioxidant activities (mean ± SD) of β-carotene (BC) isomers and metabolites (at 10 µM) determined by αTEAC (A), FRAP (B) and CL (C) assay with respect to α-tocopherol (α-TE, α-tocopherol equivalents); different superscript letters denote significant differences (ANOVA, post-hoc Student-Newman-Keuls, p < 0.05). For abbreviations see Figure 1.
Figure 2. Antioxidant activities (mean ± SD) of β-carotene (BC) isomers and metabolites (at 10 µM) determined by αTEAC (A), FRAP (B) and CL (C) assay with respect to α-tocopherol (α-TE, α-tocopherol equivalents); different superscript letters denote significant differences (ANOVA, post-hoc Student-Newman-Keuls, p < 0.05). For abbreviations see Figure 1.
Molecules 16 01055 g002
Transition metals, such as iron (III) and copper (II), play an important role in the oxidation of LDL in vitro as well as in vivo, leading to atherosclerosis [42]. BC and other carotenoids have potential antioxidant properties [15], and they were found to be incorporated into LDL particles. However, in our in vitro studies, none of the BC isomers showed ferric reducing activity [Figure 2(B)] under the used conditions, which support the findings of Pulido and co-workers [43]. This may be due to the circumstance that the ferric ion is incorporated into the steric demanding di-tripyridyltriazine (TPTZ) complex, which was first applied by Benzie and Strain [44]. Our recently published findings using α-carotene, β-carotene, lycopene and a variety of xanthophylls in the FRAP assay supports this hypothesis. It was shown, that lycopene with its acyclic polyene structure showed FRAP activity. The insertion of a hydroxyl function into bicyclic carotenes (leading to e.g. β-cryptoxanthin and zeaxanthin) induced the activity to reduce ferric ions using the TPTZ complex method [34]. The buckle in cis-isomers of BC, which may open the molecule to be more assailable to react with large steric demanding oxidants, such as ferric di-TPTZ in the FRAP assay, in our case, did not influence the activity of BC.
The noxious effects of an uncontrolled production of oxygen- and nitrogen-centered radicals (ROS, RNS) are amplified by chain reactions (autoxidations), sustained mainly by peroxyl radicals (ROO●), that oxidize and alter essential biomolecules such as lipids, lipoproteins, proteins and nucleic acid [45,46]. Krinsky and Johnson [2] proposed that ROO● might add to any place across the polyene chain of a carotenoid, resulting in the formation of a resonance-stabilized, carbon-centered radical (ROO-CAR●). Unfortunately, radical-carotenoid reaction products or stabilized carotenoid radicals were not detected in vivo to date. Additionally, ROO● can abstract an allylic hydrogen atom at the periphery of the carotenoid, in the case of BC at the 4- and 4’-position [47]. In the present study, the ROO● were formed by thermal degradation of AAPH at 37 °C. The analyzed (all-E)-form of BC presented a ROO● scavenging activity, being approx. 20-times higher than that of α-tocopherol [Figure 2(C)]. Hence, β-carotene and its isomers could play a role in the endogenous antioxidant defense system despite their lower concentrations found in human tissues compared to tocopherols. The high scavenging rate found in the present studies supports our recent observations and that of other research groups using typical synthetic ROO● generating azo-initiators such as AAPH, AMVN or AIBN [34,48,49,50,51]. The insertion of a cis-double bond at C9 or C13 did not change the antioxidant activity of BC (p > 0.05), whereas (15Z)-BC (9.5 mol α-TE/mol) was half as active (p < 0.05) as (all-E)-BC (18.8 mol α-TE/mol) probably caused by oxidative degradation during the analysis as explained for the αTEAC assay above.
Within the investigated BC metabolites, 6’-methyl-β-apo-6’-carotene-6’-one showed the highest ABTS●+ bleaching activity [Figure 2(A)], approx. 4-times higher than α-tocopherol and significantly (p < 0.05) higher than its parent molecule (all-E)-BC (3.0 mol α-TE/mol), which has the same number of conjugated double bonds (CDB) in the polyene chain. The degradation of BC to β-apo-8’-carotenal and its related carotenoic acid ester led to a significant (p < 0.05) decrease of CDB and therefore to a decrease of αTEAC activity. The β-apo-8’-carotenal (1.4 mol α-TE/mol) was only 40% more active than α-tocopherol (1 mol α-TE/mol) and only half as active as (all-E)-BC (3.0 mol α-TE/mol), due to its shorter polyene chain system and the electron-withdrawing effect of the carbonyl function. This circumstance causes a higher ionization potential of β-apo-8’-carotenal (4.676 eV) compared to BC (4.414 eV) calculated by Galano [52]. Ionization potentials of compounds are important in SET-based assays such as αTEAC and FRAP assay. In contrast, the change in the terminal function to a carboxylic acid ester with equal chain length led to an comparable activity to (15Z)-BC (2.5 mol α-TE/mol), possibly caused by an inductive effect inserted by esterification of the carbonyl function.
Surprisingly, the breakdown of BC to its metabolites caused a significant increase (p < 0.05) of the ferric reducing activity, which supports the hypothesis, that the existence of two non-substituted β-ionone rings has caused the absent FRAP activity of BC. The cleavage of BC to its metabolites, forming a structure with only one β-ionone ring and an oxygenated functional group at the opposite side, led to a significant increase of the ferric reducing activity. The three BC metabolites showed FRAP values being 25% higher than that of α-tocopherol, however, without any significant differences (p > 0.05) concerning the length of the conjugated chain or terminal function [Figure 2(B)] of the compounds.
The three investigated BC breakdown products were highly efficient in preventing luminol oxidation (23.8-25.1 mol α-TE/mol). The degradation of BC to these metabolites led to a significant (p < 0.05) increase in the ROO● scavenging activity of approx. 25% [Figure 2(C)]. A significant dependence on chain length or carbonyl related function was not observed (p > 0.05). ROO● can abstract a hydrogen atom at each position of the polyene chain [2]. In consequence, the type of terminal function has only significant influence on the reaction between carotenoid and radical if the conjugated double bond system expands. The increase of the activity to scavenge ROO● radicals by insertion of carbonyl functions into the polyene molecule was described several times for BC and its related ketocarotenoids echinenone, canthaxanthin, and astaxanthin [34,49,53]. Carotenoids such as BC can prevent the propagation phase of lipid peroxidation. As known from fatty acid oxidation, the final result of this reaction is degradation of the whole molecule into small polar products. BC should be regarded as peroxidation substrate as well as antioxidative compound [17]. Our studies show that the long-chained non-enzymatic metabolites such as β-apo-8’-carotenal are able to act as substrate in peroxidation and could protect fatty acids from oxidation, too. However, due to the very low amounts of BC metabolites found in vivo compared to tocopherols and carotenoids, BC metabolites might be not of relevance for the antioxidant defense system in human organism.
As stressed by Huang et al. [54], no single method is adequate for evaluating the antioxidant activity of single compounds or antioxidant capacity of foods or biological samples. Methods based on different mechanistic principles can yield widely diverging results. A variety of methods must be used. In the present study, two different principles were used: αTEAC and FRAP assay measures reducing activity, whereas CL determined ROO● scavenging activity. Standardization is needed by a calculation of the results achieved in the three assays. A simple mathematical treatment is not indicated, because the CL assay gave much higher values due to the low activity of α-tocopherol in this assay. To give no substance in any assay undue preponderance, calculating a global antioxidant activity as a weighted average of the results is necessary [55]. First, the antioxidant activity of the compound detected in the specific method was divided by the average activity of the whole set of compounds by the same method. Afterwards, the calculated values of the specific compounds in each assay were summed and divided by the number of assays used (three in our case). The resulting weighted averages of each compound are given in Table 1 (last column).
Table
Table 1. Antioxidant activities (mol α-TE/mol) of β-carotene isomers and metabolites standardized with respect to α-tocopherol measurement.
Table 1. Antioxidant activities (mol α-TE/mol) of β-carotene isomers and metabolites standardized with respect to α-tocopherol measurement.
CompoundαTEACFRAPCLWeighted average
α-tocopherol1.01.01.00.7
β-carotene isomers(all-E)-β-carotene3.00.018.80.8
(9Z)-β-carotene3.10.019.80.8
(13Z)-β-carotene3.10.019.60.8
(15Z)-β-carotene2.50.09.50.5
β-carotene metabolitesβ-apo-8’-carotenal1.41.323.81.3
β-apo-8’-carotenoic acid ethyl ester2.51.325.11.5
6’-methyl-β-apo-6’-carotene-6’-one3.71.324.51.7
Average 2.50.617.8
The right-hand column shows the weighted averages (mol α-TE/mol) obtained by (1) dividing the antioxidant activity of each compound, as determined by the specified method, by the average activity determined for the whole set of compounds by the same method (last row), (2) summing the results of the three assays for the specific compound (αTEAC, FRAP, and CL), and (3) dividing the sum by three.
On this basis, the four analyzed BC isomers showed antioxidant activities comparable to that of α-tocopherol (0.5-0.8 mol α-TE/mol) due to the absent ferric reducing activity of BC-isomers, whereas α-tocopherol displayed a poor CL value. Almost two-times higher activities were observed for the BC breakdown products, with 6’-methyl-β-apo-6’-carotene-6’-one as the most active one (weighted average of 1.7 α-TE/mol).
In addition to our findings on antioxidant activities of BC metabolites, the pro-oxidative effects have to be kept in mind as well. β-apo-8’-Carotenal was shown to be a strong inducer of cytochromes P4501A1 and 1A2 in rat liver, whereas BC itself was not active [56]. Induced cytochrome P450 enzymes could enhance the activation of carcinogens. Oxidative degradation products of BC could also increase the binding rate of benzo[a]pyrene to DNA [57] and may impair mitochondrial function [58,59,60]. And β-apo-8’-carotenal was shown to bound to 2’-deoxyguanosine in vitro [61]. In contrast, various beneficial activities were demonstrated in vitro for oxidation products of non-provitamin A carotenoids e.g. lycopene [62].

Conclusions

According to our knowledge this is the first study presenting antioxidant activity data of β-carotene (BC) isomers and their metabolites using different types of in vitro assays. For the first time, BC related compounds were compared based on their ABTS●+ bleaching and ferric reducing activity, as well as on their ROO● radical scavenging activity. All results were compared to the activity of α-tocopherol, which is known as the most active chain breaking and major fat-soluble antioxidant in human tissues. The activity of carotenoids to reduce ferric ions is an important property, because transition metals play an important role in catalyzing LDL oxidation in vitro and in vivo, leading to atherosclerosis. However, in the present study, ferric reducing activity was detected for BC metabolites, but not for the different BC isomers. Additionally, scavenging activities of the investigated compounds against ROO● generated by thermal degradation of AAPH were 10-25-times higher than that of α-tocopherol. ROO● are important for the initiation of lipid peroxidation chain reactions in food as well as in biological samples. All analyzed BC isomers showed 2.5-3-times higher activity in bleaching ABTS●+ than α-tocopherol. Dependence on the antioxidant activity from chain length and terminal group of the β-apo-carotenoids was only observed in the activity of bleaching ABTS●+, but not in the more in vivo relevant activities like reducing ferric and scavenging ROO●. The results of the different assays were summarized by calculating a weighted average for each BC compound to get an overall impression of the antioxidant potential. On this basis, the global antioxidant activity of the BC isomers was comparable to that of α-tocopherol. The activity of breakdown products of BC was twice as high.

Experimental

General

2,2´-Azinobis(3-ethylbenzothiazoline-6-sulphonic acid) diammonium salt (ABTS), K2S2O8, and 2,4,6-tripyridyltriazine (TPTZ) were obtained from Sigma-Aldrich (Taufkirchen, Germany). 2,2´-Azobis(2-amidinopropane) dihydrochloride (AAPH) was obtained from Acros Organics (Schwerte, Germany). Luminol was purchased from Fluka (Buchs, Switzerland). DL-α-Tocopherol was purchased from Calbiochem (Darmstadt, Germany) with a purity of 100% shown by GC. β-Carotene (BC) isomers, 6’-methyl-β-apo-6’-carotene-6’-one (citranaxanthin), β-apo-8’-carotenal and β-apo-8’-carotenoic acid ethyl ester were obtained from CaroteNature (Lupsingen, Switzerland) with a purity of 97-99% by HPLC. All solvents used, such as tert-butyl methyl ether (TBME) or dimethyl sulfoxide (DMSO), were of HPLC grade. HPLC grade water (18 MΩ) was prepared using a Millipore Milli-Q purification system (Millipore GmbH, Schwalbach, Germany). Buffer salts for phosphate buffered saline (PBS), borax buffer and acetic acid buffer and all other chemicals were of analytical grade.

Equipment

An ABTS●+ solution was prepared in phosphate buffered saline (PBS, 75 mM, pH 7.4) to measure the activity of the BC compounds to bleach ABTS●+ in the αTEAC (α-tocopherol equivalent antioxidant activity) assay as described in several publications [19,33,63]. To determine the ferric reducing antioxidant power (FRAP) of BC and its derivatives, a FRAP reagent was prepared as recently described [63,64]. The analysis of the ROO● radical scavenging activity in a chemiluminescence (CL) based assay followed the descriptions as published recently [61]. A luminol solution in DMSO+borax buffer (80+20, v/v) as well as an AAPH solution in DMSO+PBS (80+20, v/v) was prepared daily fresh, and cooled until analysis. Stock solutions of (all-E)-BC, its (Z)-isomers and metabolites were prepared by dissolving the compounds in toluene+cylohexane (1+4, v/v) to concentrations of 150 µmol/L. A 2.5 mmol/L α-tocopherol stock solution was prepared in ethanol. All stock solutions were stored at -25 ± 2 °C. Prior to analysis, aliquots of the stock solutions were transferred into reaction tubes and the solvent was removed under nitrogen at 30±1 °C in darkness. The residues were immediately dissolved in n-hexane (for the use in FRAP and αTEAC assay) or tert-butyl methyl ether (TBME)+DMSO (1+9, v/v) for the application in the CL assay. Concentrations of the compounds were adjusted to 100 µmol/L by spectrophotometrical determination using the absorptivity values (E1 %, 1 cm) at the specific wavelengths listed in Table 2.
Table
Table 2. Absorptivity values at specific wavelength maxima in specific solvent, and solvent used for stock solutions of analyzed β-carotene isomers and metabolites and α-tocopherol [65,66,67,68].
Table 2. Absorptivity values at specific wavelength maxima in specific solvent, and solvent used for stock solutions of analyzed β-carotene isomers and metabolites and α-tocopherol [65,66,67,68].
CompoundSolventWavelength (nm)Absorptivity value ( E1%,1 cm)Solvent used for stock solution
( all-E)-β-carotenen-hexane4532592T/CH (1+4, v/v)
( 9Z)-β-carotenen-hexane4452550T/CH (1+4, v/v)
( 13Z)-β-carotenen-hexane4432090T/CH (1+4, v/v)
( 15Z)-β-carotenen-hexane4471820T/CH (1+4, v/v)
β-apo-8’-carotenalethanol4572640ethanol
β-apo-8’-carotinoic acid ethyl estercyclo-hexane4462540ethanol
6’-methyl-β-apo-6’-carotene-6’-one n-hexane4682745T/CH (1+4, v/v)
DL-α-tocopherolethanol29275.8ethanol
T/CH, toluene+cyclohexane
The compounds were analyzed on FRAP and αTEAC activity in a V-530 spectrophotometer (JASCO, Groß-Umstadt, Germany) using half-micro cuvettes (1.5 mL, polystyrene; Plastibrand, Wertheim, Germany). A microplate reader FluoStar Optima (BMG Labtech, Offenburg, Germany) was used to analyze ROO● radical scavenging activity in the CL assay. The antioxidant activity was calculated using a dose-response curve for α-tocopherol (approx. 5-250 µM) in n-hexane (for αTEAC and FRAP assay) or in TBME+DMSO (1+9, v/v) for CL assay, respectively [63]. The pure solvents were used as blank in the specific assay. The antioxidant activity of BC and its metabolites in each assay was calculated as mol α-tocopherol equivalents (α-TE)/mol compound.

Determination of antioxidant activity

αTEAC, FRAP and CL assay to assess the antioxidant activity of BC isomers and its metabolites were done as described by our research group [34]. αTEAC assay was performed by mixing ABTS●+ working solution with solutions of BC isomers, its metabolites or with α-tocopherol standard. Thereafter, the mixture was completely transferred into cuvettes and centrifuged. Finally, the absorbance of the lower phase (ABTS layer) was measured at 734 nm. To assess the FRAP activity of these lipophilic compounds, solutions of α-tocopherol standard, BC isomer or metabolite were mixed with FRAP reagent. After transferring the mixed solution into cuvettes, and subsequent centrifugation, the absorbance of the aqueous layer was measured at 595 nm. To quantify the ROO● radical scavenging activity of the BC compounds, a CL assay was performed, using luminol as CL dye and AAPH as ROO● generator [69]. The assay was carried out in white 96-well Lumitrac micro plates (Greiner Bio-One, Frickenhausen, Germany). Luminol solution (in DMSO+borax buffer), solution of BC compound or α-tocopherol standard in TBME+DMSO (9+1, v/v), were combined in the wells of the micro plate. After addition of AAPH solution, the instrument was started to record the luminescence signals [34].

Statistics

All analyses were performed in triplicate at four different concentrations of each BC compound (1-20 µmol/L). Differences of the antioxidant activity between (all-E)-β-carotene, its (Z)-isomers and its metabolites were calculated using one way analysis of variance (ANOVA) with Student-Newman-Keuls post-hoc procedure, with a level of significance at p < 0.05 (SPSS for Windows, version 18.0; SPSS Inc., Chicago, IL).

References

  1. Maiani, G.; Caston, M.J.; Catasta, G.; Toti, E.; Cambrodon, I.G.; Bysted, A.; Granado-Lorencio, F.; Olmedilla-Alonso, B.; Knuthsen, P.; Valoti, M.; Böhm, V.; Mayer-Miebach, E.; Behsnilian, D.; Schlemmer, U. Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in human. Mol. Nutr. Food Res. 2009, 53, S194–S218. [Google Scholar] [CrossRef]
  2. Krinsky, N.I.; Johnson, E.J. Carotenoid actions and their relation to health and disease. Mol. Aspects Med. 2005, 26, 459–516. [Google Scholar] [CrossRef]
  3. Rodriguez-Amaya, D.B.; Kimura, M.; Godoy, H.T.; Amaya-Farfan, J. Updated Brazilian database on food carotenoids: Factors affecting carotenoid composition. J. Food Compos. Anal. 2008, 21, 445–463. [Google Scholar] [CrossRef]
  4. Zechmeister, L.; Tuzson, P. Isomerization of carotenoids. Biochem. J. 1938, 32, 1305–1311. [Google Scholar]
  5. Castenmiller, J.J.; West, C.E. Bioavailability and bioconversion of carotenoids. Annu. Rev. Nutr. 1998, 18, 19–38. [Google Scholar] [CrossRef]
  6. Failla, M.L.; Thakkar, S.K.; Kim, J.Y. In vitro bioaccessibility of β-carotene in orange fleshed sweet potato (Ipomoea batatas, Lam.). J. Agric. Food Chem. 2009, 57, 10922–10927. [Google Scholar] [CrossRef]
  7. Deming, D.M.; Erdman, J.W., Jr. Mammalian carotenoid absorption and metabolism. Pure Appl. Chem. 1999, 71, 2213–2223. [Google Scholar] [CrossRef]
  8. Khachik, F.; Spangler, C.J.; Smith, J.C., Jr.; Canfield, L.M. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal. Chem. 1997, 69, 1873–1881. [Google Scholar] [CrossRef]
  9. Stahl, W.; Schwarz, W.; Sundquist, A.R.; Sies, H. cis-trans isomers of lycopene and β-carotene in human serum and tissues. Arch. Biochem. Biophys. 1992, 294, 173–177. [Google Scholar] [CrossRef]
  10. Voutilainen, S.; Nurmi, T.; Mursu, J.; Rissanen, T.H. Carotenoids and cardiovascular health. Am. J. Clin. Nutr. 2006, 83, 1265–1271. [Google Scholar]
  11. Agte, V.; Tarwadi, K. The importance of nutrition in the prevention of ocular disease with special reference to cataract. Ophthalmic Res. 2010, 44, 166–172. [Google Scholar] [CrossRef]
  12. Kubo, A.; Corley, D.A.; Jensen, C.D.; Kaur, R. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr. Res. Rev. 2010, 23, 230–246. [Google Scholar] [CrossRef]
  13. Glauert, H.P.; Calfee-Mason, K.; Stemm, D.N.; Tharappel, J.C.; Spear, B.T. Dietary antioxidants in the prevention of hepatocarcinogenesis: A review. Mol. Nutr. Food Res. 2010, 54, 875–896. [Google Scholar] [CrossRef]
  14. Cranganu, A.; Camporeale, J. Nutrition aspects of lung cancer. Nutr. Clin. Pract. 2009, 24, 688–700. [Google Scholar] [CrossRef]
  15. Riccioni, G. Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep. 2009, 11, 434–439. [Google Scholar] [CrossRef]
  16. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 1989, 274, 532–538. [Google Scholar] [CrossRef]
  17. Levin, G.; Mokady, S. Antioxidant activity of 9-cis compared to all-trans β-carotene in vitro. Free Radic. Biol. Med. 1994, 17, 77–82. [Google Scholar] [CrossRef]
  18. Levin, G.; Yeshurun, M.; Mokady, S. In vivo antiperoxidative effect of 9-cis β-carotene compared with that of the all-trans isomer. Nutr. Cancer 1997, 27, 293–297. [Google Scholar] [CrossRef]
  19. Böhm, V.; Puspitasari-Nienaber, N.L.; Ferruzzi, M.G.; Schwartz, S.J. Trolox equivalent antioxidant capacity of different geometrical isomers of α-carotene, β-carotene, lycopene, and zeaxanth. J. Agric. Food Chem. 2002, 50, 221–226. [Google Scholar] [CrossRef]
  20. Patrick, L. Beta-carotene: the controversy continues. Altern. Med. Rev. 2000, 5, 530–545. [Google Scholar]
  21. Palozza, P.; Simone, R.; Mele, M.C. Interplay of carotenoids with cigarette smoking: implications in lung cancer. Curr. Med. Chem. 2008, 15, 844–854. [Google Scholar] [CrossRef]
  22. Leneberger, M.G.; Engeloch-Jarret, C.; Woggon, W.-D. The reaction mechanism of the enzyme-catalyzed central cleavage of β-carotene in retinal. Angew. Chem., Int. Ed. 2001, 40, 2614–2617. [Google Scholar]
  23. Yeum, K.J.; Russell, R.M. Carotenoid bioavailability and bioconversion. Annu. Rev. Nutr. 2002, 22, 483–504. [Google Scholar] [CrossRef]
  24. von Lintig, J.; Hessel, S.; Isken, A.; Kiefer, C.; Lampert, J.M.; Voolstra, O.; Vogt, K. Towards a better understanding of carotenoid metabolism in animals. Biochim. Biophys. Acta 2005, 1740, 122–131. [Google Scholar] [CrossRef]
  25. Wang, X.D.; Tang, G.W.; Fox, J.G.; Krinsky, N.I.; Russell, R.M. Enzymatic conversion of β-carotene into β-apo-carotenals and retinoids by human, monkey, ferret, and rat tissues. Arch. Biochem. Biophys. 1991, 285, 8–16. [Google Scholar] [CrossRef]
  26. Nagao, A. Oxidative conversion of carotenoids to retinoids and other products. J. Nutr. 2004, 134, 237S–240S. [Google Scholar]
  27. Ho, C.C.; de Moura, F.F.; Kim, S.H.; Clifford, A.J. Excentral cleavage of β-carotene in vivo in a healthy man. Am. J. Clin. Nutr. 2007, 85, 770–777. [Google Scholar]
  28. Weedon, B.C.L. II. Occurence. In Carotenoids; O., Isler, Ed.; Birkhäuser Verlag: Basel, 1976; pp. 29–60. [Google Scholar]
  29. Barua, A.B.; Olson, J.A. β-Carotene is converted primarily to retinoids in rats in vivo. J. Nutr. 2000, 130, 1996–2001. [Google Scholar]
  30. Alija, A.J.; Bresgen, N.; Sommerburg, O.; Langhans, C.D.; Siems, W.; Eckl, P.M. Cyto- and genotoxic potential of β-carotene and cleavage products under oxidative stress. Biofactors 2005, 24, 159–163. [Google Scholar] [CrossRef]
  31. Mortensen, A.; Skibsted, L.H.; Truscott, T.G. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys. 2001, 385, 13–19. [Google Scholar] [CrossRef]
  32. Lavy, A.; Ben Amotz, A.; Aviram, M. Preferential inhibition of LDL oxidation by the all-trans isomer of β-carotene in comparison with 9-cis β-carotene. Eur. J. Clin. Chem. Clin. Biochem. 1993, 31, 83–90. [Google Scholar]
  33. Miller, N.J.; Sampson, J.; Candeias, L.P.; Bramley, P.M.; Rice-Evans, C.A. Antioxidant activities of carotenes and xanthophylls. FEBS lett. 1996, 384, 240–242. [Google Scholar] [CrossRef]
  34. Müller, L.; Fröhlich, K.; Böhm, V. Comparative antioxidant activities of carotenoids measured by ferric reducing antioxidant power (FRAP), ABTS bleaching assay (αTEAC), DPPH assay and peroxyl radical scavenging assay. Food Chem. 2010. submitted. [Google Scholar]
  35. Böhm, H.; Boeing, H.; Hempel, J.; Raab, B.; Kroke, A. Flavonols, flavones, and anthocyanins as native antioxidants of food and their possible role in the prevention of chronic diseases. Z. Ernährungswiss. 1998, 37, 147–163. [Google Scholar] [CrossRef]
  36. Halliwell, B.; Rafter, J.; Jenner, A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 2005, 81, 268S–276S. [Google Scholar]
  37. El-Agamey, A.; Lowe, G.M.; McGarvey, D.J.; Mortensen, A.; Phillip, D.M.; Truscott, T.G.; Young, A.J. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch. Biochem. Biophys. 2004, 430, 37–48. [Google Scholar] [CrossRef]
  38. Kamal-Eldin, A.; Appelqvist, L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31, 671–701. [Google Scholar] [CrossRef]
  39. Young, A.J.; Lowe, G.M. Antioxidant and prooxidant properties of carotenoids. Arch. Biochem. Biophys. 2001, 385, 20–27. [Google Scholar] [CrossRef]
  40. Guo, W.H.; Tu, C.Y.; Hu, C.H. Cis-trans isomerizations of β-carotene and lycopene: a theoretical study. J. Phys. Chem. 2008, 112, 12158–12167. [Google Scholar] [CrossRef]
  41. Ceron-Carrasco, J.P.; Bastida, A.; Zuniga, J.; Requena, A.; Miguel, B. Density functional theory study of the stability and vibrational spectra of the β-carotene isomers. J. Phys. Chem. 2009, 113, 9899–9907. [Google Scholar] [CrossRef]
  42. Yoshida, H.; Kisugi, R. Mechanisms of LDL oxidation. Clin. Chim. Acta 2010, 411, 1875–1822. [Google Scholar] [CrossRef]
  43. Pulido, R.; Bravo, L.; Saura-Calixto, F. Antioxidant activity of dietary polyphenols as determined by a modified ferric reducing/antioxidant power assay. J. Agric. Food Chem. 2000, 48, 3396–3402. [Google Scholar] [CrossRef]
  44. Benzie, I.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar]
  45. Spiteller, G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic. Biol. Med. 2006, 41, 362–387. [Google Scholar] [CrossRef]
  46. Foti, M.C.; Amorati, R. Non-phenolic radical-trapping antioxidants. J. Pharm. Pharmacol. 2009, 61, 1435–48. [Google Scholar]
  47. Woodall, A.A.; Lee, S.W.-M.; Weesie, R.J.; Jackson, M.J.; Britton, G. Oxidation of carotenoids by free radicals: relationship between structure and reactivity. Biochim. Biophys. Acta 1997, 1336, 33–42. [Google Scholar] [CrossRef]
  48. Burton, G.W.; Ingold, K.U. β-Carotene: an unusual type of lipid antioxidant. Science 1984, 224, 569–573. [Google Scholar]
  49. Terao, J. Antioxidant activity of β-carotene-related carotenoids in solution. Lipids 1989, 24, 659–661. [Google Scholar] [CrossRef]
  50. Tsuchiya, M.; Scita, G.; Freisleben, H.J.; Kagan, V.E.; Packer, L. Antioxidant radical-scavenging activity of carotenoids and retinoids compared to α-tocopherol. Meth. Enzym. 1992, 213, 460–472. [Google Scholar] [CrossRef]
  51. Woodall, A.A.; Britton, G.; Jackson, M.J. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: Relationship between carotenoid structure and protective ability. Biochim. Biophys. Acta 1997, 1336, 575–586. [Google Scholar] [CrossRef]
  52. Galano, A. Relative antioxidant efficiency of a large series of carotenoids in terms of one electron transfer reactions. J. Phys. Chem. B 2007, 111, 12898–12908. [Google Scholar] [CrossRef]
  53. Naguib, Y.M.A. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48, 1150–1154. [Google Scholar] [CrossRef]
  54. Huang, D.; Ou, B.; Prior, R.L. The chemistry behind antioxidant capacity assays. J. Agric. Food Chem. 2005, 53, 1841–1856. [Google Scholar] [CrossRef]
  55. Tabart, J.; Kevers, C.; Pincemail, J.; Defraigne, J.-O.; Dommes, J. Comparative antioxidant capacities of phenolic compounds measured by various tests. Food Chem. 2009, 113, 1226–1233. [Google Scholar] [CrossRef]
  56. Gradelet, S.; Leclerc, J.; Siess, M.H.; Astorg, P.O. β-apo-8'-Carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 1996, 26, 909–919. [Google Scholar] [CrossRef]
  57. Salgo, M.G.; Cueto, R.; Winston, G.W.; Pryor, W.A. β-Carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic. Biol. Med. 1999, 26, 162–173. [Google Scholar] [CrossRef]
  58. Siems, W.; Sommerburg, O.; Schild, L.; Augustin, W.; Langhans, C.D.; Wiswedel, I. β-Carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. FASEB J. 2002, 16, 1289–1291. [Google Scholar]
  59. Siems, W.; Wiswedel, I.; Salerno, C.; Crifo, C.; Augustin, W.; Schild, L.; Langhans, C.D.; Sommerburg, O. β-Carotene breakdown products may impair mitochondrial functions - potential side effects of high-dose β-carotene supplementation. J. Nutr. Biochem. 2005, 16, 385–397. [Google Scholar] [CrossRef]
  60. Siems, W.; Salerno, C.; Crifo, C.; Sommerburg, O.; Wiswedel, I. β-Carotene degradation products - formation, toxicity and prevention of toxicity. Forum Nutr. 2009, 61, 75–86. [Google Scholar] [CrossRef]
  61. Marques, S.A.; Loureiro, A.P.; Gomes, O.F.; Garcia, C.C.; Di Mascio, P.; Medeiros, M.H. Induction of 1,N(2)-etheno-2'-deoxyguanosine in DNA exposed to β-carotene oxidation products. FEBS lett. 2004, 560, 125–130. [Google Scholar] [CrossRef]
  62. Carail, M.; Caris-Veyrat, C. Carotenoid oxidation products: from villain to saviour? Pure Appl. Chem. 2006, 78, 1493–1503. [Google Scholar] [CrossRef]
  63. Müller, L.; Theile, K.; Böhm, V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol. Nutr. Food Res. 2010, 54, 731–742. [Google Scholar] [CrossRef]
  64. Jimenez-Alvarez, D.; Giuffrida, F.; Vanrobaeys, F.; Golay, P.A.; Cotting, C.; Lardeau, A.; Keely, B.J. High-throughput methods to assess lipophilic and hydrophilic antioxidant capacity of food extracts in vitro. J. Agric. Food Chem. 2008, 56, 3470–3477. [Google Scholar] [CrossRef]
  65. Olmedilla, B.; Granado, F.; Rojas-Hidalgo, E.; Blanco, I. A rapid separation of ten carotenoids, three retinoids, α-tocopherol and D-α-tocopherol acetate by high performance liquid chromatography and its application to serum and vegetable samples. J. Liq. Chromatogr. 1990, 13, 1455–1483. [Google Scholar] [CrossRef]
  66. Schierle, J.; Härdi, W.; Faccin, N.; Bühler, I.; Schüep, W. Example 8: Geometrical isomers of β,β-carotene. A rapid routine method for quantitative determination. In Carotenoids; Britton, G., Liaaen-Jensen, S., Pfander, H., Eds.; Birkhäuser Verlag: Basel, Switzerland, 1995; pp. 265–272. [Google Scholar]
  67. Naumann, C.; Bassler, R. Die chemische Untersuchung von Futtermitteln; VDLUFA-Verlag: Darmstadt, Germany, 1976. [Google Scholar]
  68. Franke, A.A.; Murphy, S.P.; Lacey, R.; Custer, L.J. Tocopherol and tocotrienol levels of foods consumed in Hawaii. J. Agric. Food Chem. 2007, 55, 769–778. [Google Scholar]
  69. Lissi, E.; Pascual, C.; Del Castillo, M.D. Luminol luminescence induced by 2,2'-azo-bis(2-amidinopropane) thermolysis. Free Radic Res. Comm. 1992, 17, 299–311. [Google Scholar] [CrossRef]
  • Sample Availability: All compounds are commercially available.

Share and Cite

MDPI and ACS Style

Mueller, L.; Boehm, V. Antioxidant Activity of β-Carotene Compounds in Different in Vitro Assays. Molecules 2011, 16, 1055-1069. https://doi.org/10.3390/molecules16021055

AMA Style

Mueller L, Boehm V. Antioxidant Activity of β-Carotene Compounds in Different in Vitro Assays. Molecules. 2011; 16(2):1055-1069. https://doi.org/10.3390/molecules16021055

Chicago/Turabian Style

Mueller, Lars, and Volker Boehm. 2011. "Antioxidant Activity of β-Carotene Compounds in Different in Vitro Assays" Molecules 16, no. 2: 1055-1069. https://doi.org/10.3390/molecules16021055

Article Metrics

Back to TopTop